Poxviral oncolytic vectors
US9687515B2 · kind B2 · utility
2Cited by
5References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 10, 2014 |
| Grant date | Jun 27, 2017 |
| Priority date | — |
| Expiry date | Aug 9, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y305/04001
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a poxvirus comprising a defective F4L and/or I4L gene, to composition comprising such poxvirus and to the methods and use of such compositions and poxviruses for therapeutic purposes, and more particularly for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.